DONATE

Advance in research against childhood cancer in the #WorldResearchCancerDay

IBEC researchers appear in different media for the recent study senior-authored by Joan Montero and first-authored by Albert Manzano, Senior Researcher and PhD student in IBEC’s Nanobioengineering group in which they have used a state-of-the-art analysis technique to evaluate new drug combinations to successfully treat acute lymphoblastic leukemia.

BiofilmChip protagonist in the media

Researchers from the Institute for Bioengineering of Catalonia (IBEC), led by Eduard Torrents, leader of the group “bacterial infections and antimicrobial therapies” and professor at the University of Barcelona (UB), in collaboration with Josep Samitier, principal investigator of the group “Nanobioingineering” of IBEC, and Maite Martin, of the Vall d’Hebron Barcelona Hospital appear in the media for the new device, called BiofilmChip, which allows a custom and precise diagnosis of chronic infections.

High-intensity rehabilitation for stroke recovery

ICREA Research Professor Paul Verschure and Belén Rubio Ballester —Group Leader and Postdoctoral Researcher at IBEC’s Synthetic, Perceptive, Emotive and Cognitive Systems (SPECS) Group, appear in the media because of their collaborative study with Nick S. Ward de la UCL about a retrospective analysis that concludes that high-intensity therapy beginning within 6 months post-stroke offers the best rehabilitation outcomes, suggesting that standards of care offered by many healthcare systems should be re-analysed.